Karyopharm Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Karyopharm Therapeutics Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2012 to Q3 2024.
  • Karyopharm Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 125M shares, a 9.41% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 125M +10.8M +9.41% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 125M +10.3M +9% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 116M +2.49M +2.18% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 115M +1.7M +1.5% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 115M +33.5M +41.3% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 114M +34.5M +43.3% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 114M +34.6M +43.5% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 113M +37.5M +49.5% Dec 31, 2022 10-K 2024-02-29
Q3 2022 81M +5.53M +7.32% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 79.8M +4.46M +5.93% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 79.4M +4.36M +5.81% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 75.7M +1.82M +2.47% Dec 31, 2021 10-K 2023-02-17
Q3 2021 75.5M +1.97M +2.69% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 75.3M +1.97M +2.68% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 75.1M +1.97M +2.69% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 73.9M +8.55M +13.1% Dec 31, 2020 10-K 2022-03-01
Q3 2020 73.5M +10.8M +17.3% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 73.4M +12.4M +20.3% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 73.1M +12.2M +20.1% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 65.4M +4.54M +7.47% Dec 31, 2019 10-K 2021-02-24
Q3 2019 62.7M +2.04M +3.36% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 61M +464K +0.77% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 60.9M +11.2M +22.5% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 60.8M +11.3M +22.8% Dec 31, 2018 10-K 2020-02-26
Q3 2018 60.7M +13.5M +28.7% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 60.5M +13.4M +28.4% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 49.7M +7.77M +18.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 49.5M +7.65M +18.3% Dec 31, 2017 10-K 2019-02-28
Q3 2017 47.2M +7.43M +18.7% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 47.1M +11.1M +30.9% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 41.9M +5.98M +16.6% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 41.9M +6.02M +16.8% Dec 31, 2016 10-K 2018-03-15
Q3 2016 39.7M +4.01M +11.2% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 36M +286K +0.8% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 35.9M +238K +0.67% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 35.9M +3.17M +9.68% Dec 31, 2015 10-K 2017-03-16
Q3 2015 35.7M +3.1M +9.5% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 35.7M +5.98M +20.1% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 35.7M +6.07M +20.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 32.7M +3.11M +10.5% Dec 31, 2014 10-K 2016-03-15
Q3 2014 32.6M +30M +1159% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 29.7M Jun 30, 2014 10-Q 2014-08-07
Q1 2014 29.6M Mar 31, 2014 10-Q 2014-05-08
Q4 2013 29.6M +27.5M +1293% Dec 31, 2013 10-K 2015-03-13
Q3 2013 2.59M Sep 30, 2013 10-Q/A 2013-12-23
Q4 2012 2.12M Dec 31, 2012 10-K 2014-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.